Healthcare | January 25, 2023
75% of asthma patients have worse symptoms during cold or flu
Asthma patients are more likely to have an asthma attack during winter
Asthma patients are more likely to have an asthma attack during winter
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
The divested brands include Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands
Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of US $666 million in the US (IQVIA MAT September 2022)
The estimated national burden of asthma in India is at 17.23 million with an overall prevalence of 2.05% and out of this, approximately 30 lakh patients can be classified under “inadequately controlled”
Cipla and Ethris partner for the development of mRNA-based therapies
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
It offers quick relief in various types of Coughs, Colds and Sore Throat,
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
Subscribe To Our Newsletter & Stay Updated
